Fluorescent Labeling Compounds for Multiplex DNA Assays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for non-radioactive detection of biological analytes, particularly in multiplex DNA probe assays and DNA sequencing, face challenges with dye label selection due to constraints imposed by electrophoretic separation and enzyme treatment, necessitating a broadly applicable and shelf-stable labeling methodology.

Innovation Solution

Development of compounds with a hydroxy- or protected hydroxy-substituted fluorescent dye linked to an alkanoic acid or heteroalkanoic acid moiety, allowing for versatile labeling of biological agents with emission wavelengths between 400 nm to 1200 nm, including covalent attachment to solid supports and biological agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional dye labels are used for multiplex detection, then the detection of multiple analytes is enabled, but the selection of dye labels is constrained by electrophoretic separation and enzyme treatment requirements

Engineering Contradiction:
Improvedye label selection flexibilityVSAvoidcompatibility with electrophoretic separation and enzyme treatment
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent creates a universal labeling platform using carbodiimide chemistry that works with multiple types of fluorescent dyes (carboxyl-, hydroxyl-, and amino-substituted dyes) and biological materials (oligonucleotides, proteins, peptides). This universal approach allows the same labeling methodology to be applied across different dye types and applications, achieving versatility without compromising reliability through standardized reaction conditions and shelf-stable compound design.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If radioactive labels are used for detection of biological analytes, then detection sensitivity is achieved, but safety risks and environmental impact increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsafety risks and environmental impact
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent transitions from radioactive to non-radioactive detection by changing the detection parameter from radioactivity to fluorescence. This parameter change maintains detection sensitivity through the use of fluorescent dyes with appropriate emission wavelengths while eliminating safety risks and environmental hazards associated with radioactive materials. The carbodiimide labeling methodology enables this transition by providing efficient covalent attachment of fluorescent dyes to biological analytes.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If fluorescent dyes are used for multiplex detection, then non-radioactive detection is achieved, but the labeling methodology must be broadly applicable to various dyes and biological materials

Engineering Contradiction:
Improveradioactivity eliminationVSAvoidlabeling methodology applicability
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent introduces carbodiimide chemistry as an intermediary mechanism that facilitates the coupling between carboxyl groups on fluorescent dyes and amino groups on biological materials. This intermediary approach allows the labeling methodology to be broadly applicable to various dye types and biological materials without requiring dye-specific or material-specific protocols, thereby achieving versatility while eliminating radioactivity.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Stability of the object's composition

If compounds with hydroxy-substituted fluorescent dyes linked to alkanoic acid are developed, then shelf stability and versatility are improved, but compound complexity increases

Engineering Contradiction:
Improveshelf lifeVSAvoidcompound structure
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent creates composite fluorescent labeling compounds by combining hydroxy-substituted fluorescent dyes with alkanoic acid moieties through carbodiimide chemistry. This composite structure integrates the fluorescent properties of the dye with the reactive carboxyl group of the alkanoic acid, achieving both shelf stability and versatility in a single compound design. The composite nature of these compounds allows them to function as stable precursors that can be activated and coupled to various biological materials.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a shelf-stable and versatile fluorescent labeling solution compatible with various dyes, enabling efficient labeling of biological agents across different applications, including DNA sequencing and multiplex assays, with improved throughput and reduced uncertainties.

Implementation Method 1

The probes are prepared by covalent attachment of a fluorescent dye to an oligonucleotide

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

compounds that have an emission wavelength of from about 400 nm to about 1200 nm

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS7541454B2Compounds and methods for fluorescent labeling
Publication Date: 2009.06.02 ELITECHGROUP MDX LLC
  • US7541454B2 patent drawing
  • US7541454B2 patent drawing
  • US7541454B2 patent drawing

AI summary

Compounds useful in the fluorescent labeling of biological materials are provided along with methods for their use and preparation.